Regeneron Pharmaceuticals (REGN) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

REGN is expected to report earnings to rise 2.51% to $11.85 per share on October 31

Regeneron Pharmaceuticals REGN Stock Earnings Reports

Q3'24

Est.

$11.85

Q2'24

Beat

by $0.95

Q1'24

Missed

by $0.64

Q4'23

Beat

by $1.09

Q3'23

Beat

by $0.91

The last earnings report on August 01 showed earnings per share of $11.56, beating the estimate of $10.61. With 659.73K shares outstanding, the current market capitalization sits at 114.94B.

View a ticker or compare two or three

Compare

REGN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For REGN
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for REGN (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of medicines for the treatment of serious medical conditions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

777 Old Saw Mill River Road

Phone

+1 914 847-7000

Employees

13450

Web

https://www.regeneron.com